incretin and glp-1 The time has come for incretins, a long time coming | Journal of Molecular Medicine PDB-101: Molecule of the Month:

Pre-clinical studies demonstrate cardioprotective effects of GLP-1 agonists and favor the view that inhibition of DPP-4 resulting in increased levels of GLP-1 is one of the major pathways for CV protection by DPP-4 inhibitors [11, 12]

FDA Drug Safety Communication: FDA warns about increased risk of serious pancreatitis with irritable bowel drug Viberzi (eluxadoline) in patients without a gallbladder

Bariatric surgery patients experience it at even higher rates (5070%)

By staying hydrated, eating smart, and partnering with an experienced provider, you can take control of the side effects and stay focused on your long-term health goals

Characterized by airflow obstruction caused by chronic bronchitis and/or emphysema, COPD manifests through symptoms such as shortness of breath, excessive mucus production, and coughing (Mayo Clinic, 2023)

When performed at a certified clinic under expert supervision, the treatment is considered safe